MedTrace Logo

Blood Flow Restriction Therapy in Patellofemoral Pain Syndrome

NCT03717532 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2020-05-28

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of blood restriction therapy by comparing increase in muscle mass and strength in patients that receive blood restriction therapy to patients who receive a placebo.

Conditions

  • Patellofemoral Pain Syndrome

Interventions

PROCEDURE

Placebo

Patients will be receiving blood flow restriction therapy with a pressure cuff set to a placebo pressure setting.

PROCEDURE

Personalized Tourniquet System for Blood Flow Restriction

Patients will be receiving blood flow restriction therapy with a pressure cuff

Sponsors & Collaborators

Principal Investigators

  • Guillen Gonzalez-Lomas, MD · NYU Langone Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2019-11-01
Completion
2019-11-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03717532 on ClinicalTrials.gov